ALDH1A3 and ALDH1L1 are found to be significantly correlated to the worsened overall survival for all patients with gastric cancer and are potential prognostic markers and therapeutic targets for patients with gastric cancer [23]. This evidence concerns the gene ALDH1L1 and gastric cancer.